Wardynski & Partners has advised Bio-Rad Laboratories on its acquisition of Curiosity Diagnostics from Scope Fluidics for a total consideration of up to USD 170 million in upfront and future milestone payments. Deloitte Legal advised Scope Fluidics on the sale.
According to Wardynski & Partners, “Curiosity Diagnostics, a late-stage, pre-commercial platform company, is in the process of developing a sample-to-answer, rapid diagnostics PCR system for the molecular diagnostics market. The PCR|ONE system offers an exceptionally easy procedure to perform a genetic test in disposable cartridges, in a fully automated procedure, in an exceptionally short time of 20 minutes.”
Bio-Rad develops, manufactures, and markets a range of products for the life science research and clinical diagnostic markets. Based in Hercules, California, Bio-Rad has a network of operations with approximately 7,900 employees worldwide and USD 2.9 billion in revenues in 2021.
Wardynski & Partners’ team included Partners Katarzyna Wojcik-Bakowska and Monika Gorska, Counsel Adam Pawlisz, Associate Krzysztof Drzymala, Attorney-at-law Katarzyna Jaroszynska and Junior Lawyer Oliwia Kruczynska.
Deloitte Legal’s team included Partner Ryszard Manteuffel, Associate Partner Robert Semczuk, Senior Managing Associate Jakub Labuz, and Associate Blazej Badera.
